2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Adenoma
Adenomas are benign tumors that arise from glandular tissue. While typically non-cancerous, certain adenomas, particularly those in the colon, can progress to cancer if left untreated. Understanding the molecular mechanisms underlying this progression is crucial in cancer research. Researchers investigate genetic mutations and signaling pathways implicated in adenoma-to-carcinoma progression, aiming to identify biomarkers for early detection and targeted therapies. Advanced imaging techniques and molecular profiling help characterize adenomas and predict their malignant potential. Additionally, studying the tumor microenvironment provides insights into how adenomas interact with surrounding tissues, potentially influencing their transformation into cancer. By elucidating the complexities of adenoma biology, cancer researchers strive to develop more effective prevention and treatment strategies to reduce the burden of adenoma-associated cancers.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China